Lipitor Plaintiffs Consider Options After Evidence Barred

Women alleging Lipitor caused their diabetes are evaluating options after a ruling that excluded nearly all their evidence linking drug and disease (In re Lipitor (Atorvastatis Calcium) Mktg., Sales Prac. & Prod. Liab. Litig., D.S.C., 14-02502, 3/30/16).

Testimony from Dr. Michael Quon, Dr. Barbara Roberts and Dr. Edwin Gale—three experts who sought to connect Lipitor to diabetes in female patients at dosages of 10, 20 and 40 milligrams—was barred by Judge Richard M. Gergel of the U.S. District Court for the District of South Carolina March 30.

The court allowed testimony by Dr. Sonal Singhs that the ...